Search

Your search keyword '"Shinichiro, Uemura"' showing total 5 results
Start Over Author "Shinichiro, Uemura" Topic hemodialysis
5 results on '"Shinichiro, Uemura"'

1. IgD multiple myeloma with renal involvement: case report

Author

Terukatu Arima, Ryuji Harada, Akira Nakajima, Yoshinobu Ohtubo, Shinichiro Uemura, Hirofumi Homan, Kazuhiro Azuma, Hirohide Ito, Hideyuki Ohtuka, Yuichiro Yasumoto, Wataru Yamashita, Kenji Uomizu, and Kazuya Ohsaki

Subjects
Adult, medicine.medical_treatment, chemical and pharmacologic phenomena, Immunoelectrophoresis, Immunoglobulin D, stomatognathic system, immune system diseases, Renal Dialysis, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Multiple myeloma, Dominance (genetics), Aged, biology, medicine.diagnostic_test, business.industry, hemic and immune systems, General Medicine, Acute Kidney Injury, Middle Aged, medicine.disease, Immunology, biology.protein, Kidney Failure, Chronic, Female, Hemodialysis, IgD myeloma, business, Multiple Myeloma
Abstract

IgD multiple myeloma is a unique type of multiple myeloma which is characterized by increased serum IgD and IgD type M-component in immunoelectrophoresis. It frequently shows renal involvement but it is a rare form of myeloma. The distinctive features of IgD myeloma are the dominance in males, high frequency in younger persons, and the uncertain appearance of M-component in serum electrophoresis. We experienced 3 cases of IgD multiple myeloma with renal failure which required hemodialysis before IgD myeloma was diagnosed. It is important to consider IgD myeloma when treating the patients with renal involvement of unknown origin.

Published
1990

2. The changes of rosette forming cell of peripheral blood lymphocyte during hemodialysis

Author

Ryuji Harada, Yoshito Otsuji, Makoto Ninomiya, Shuzo Miyazawa, Shuzi Hashimoto, Takahisa Morita, Yasunaga Hamasaki, Tadashi Matsumoto, and Shinichiro Uemura

Subjects
medicine.anatomical_structure, Rosette (schizont appearance), Chemistry, medicine.medical_treatment, Peripheral blood lymphocyte, Cell, Immunology, medicine, Hemodialysis
Abstract

血液透析が免疫応答系, 特に末梢血リンパ球subpopulationに及ぼす影響について検索した. 対象は週3回の維持透析を受けている安定期の患者で, cuprophan膜を用いて透析を行っている者10例とpolycarbonate membrane (PCM) を用いている者2例とした. 方法はこれらの症例で, 透析前, 透析開始後15分, 60分, 120分に採血を行い, 白血球算定, アナリーゼ, 補体価の測定, 及び矢田らのmixed rosette法を用いてリンパ球subpopulationの測定を行った. その結果, 1) 血液透析の初期 (15分) にdouble-RFCは透析前値の38.7±13.6%にEA-RFCは52.2±18.0%に著明 (P

Published
1982

3. Lymphocyte subpopulations in hemodialysis patients

Author

Shuichi Hanada, Kazuhiro Azuma, Shinichiro Uemura, Yoshihito Otsuji, Kenji Uomizu, Etsuo Yoshidome, Hideyuki Otsuka, Toshiaki Uematsu, Kazuya Osaki, Shuji Hashimoto, Ryuji Harada, and Toshihisa Mizuta

Subjects
Lymphocyte subpopulations, business.industry, medicine.medical_treatment, Immunology, medicine, Hemodialysis, business
Abstract

血液透析 (HD) 患者の末梢血リンパ球サブポピュレーションに対する輸血, HD期間, human T cell leukemia vlrus-I (ATLV/HTLV-I) およびHB virus感染の影響を検討し, 以下の結果を得た. 1). HD期間の増加に伴いOKT8+細胞比率の増加がみられ, OKB1+細胞比率は減少した. 2) 輸血によりHD患者のLeu7+細胞比率は減少したが, OKT4/OKT8比は変化を認めなかった. 3) 抗ATLA抗体陽性を示すHD患者ではOKT4/OKT8比の幅広い分布がみられるが, 抗ATLA抗体陰性者に比しOKT4/OKT8比の有意な低下がみられ, 輸血群でのOKT4/OKT8比低値例のほとんどは抗ATしA抗体陽性あるいは長期HD例であった. 4) HBs抗原陽性群と抗HBs抗体陽性群では, リンパ球サブポピュレーションの差異はみられなかった.以上の事から, HD期間あるいは抗ATLA抗体の存在がHD患者のリンパ球サブポピュレーションの変動に関与し得ることが考えられ, 輸血によりOKT4/OKT8比が低下するという今までの報告は, ATLV/HTLV-Iあるいは他のvirus感染による可能性もうかがわれた.

Published
1987

4. Adult T Cell Leukemia in Hemodialysis Patients from the Kagoshima District, an Area in Which Human T Cell Leukemia Virus Type I Is Highly Endemic

Author

Shuji Hashimoto, Hiroaki Ueda, Toshiaki Uematsu, Shinichiro Uemura, Kazuya Osaki, Ryuji Harada, Shuichi Hanada, T Saito, Maki Otsuka, and Kazuo Komidori

Subjects
Male, viruses, medicine.medical_treatment, T-cell leukemia, Japan, Antigen, Renal Dialysis, immune system diseases, hemic and lymphatic diseases, Humans, Leukemia-Lymphoma, Adult T-Cell, Medicine, Aged, Human T-lymphotropic virus 1, biology, business.industry, Endemic area, Middle Aged, Virology, Human T cell leukemia virus, Immunology, biology.protein, Kidney Failure, Chronic, Chronic renal failure, Hemodialysis, Antibody, business
Abstract

We report 2 cases of adult T cell leukemia (ATL) from hemodialysis (HD) patients with chronic renal failure (CRF) in the Kagoshima district, an endemic area of human T cell leukemia virus type I(HTLV-I) in Japan. The positivity of antibodies to ATL-associated antigen(anti-ATLA) in HD patients, regardless of whether or not blood transfusions were given, has been higher than in healthy persons in the district (p less than 0.01). ATL is considered to break out from HTLV-I carriers. Further study should be conducted to clarify the relationship between HTLV-I infection and CRF, and moreover, attention should be directed not only to treatment of HD but accompanying ATL as well, particularly in HTLV-I-endemic areas.

Published
1989

5. The incidence of anti-ATLA (antibodies to adult T-cell leukemia-associated antigen) among hemodialysis patients in the Kagoshima district with special reference to blood transfusion

Author

Yoshihito Ostuji, Toshiaki Uematsu, Shinichiro Uemura, Shuichi Hanada, Etsuo Yoshidome, Shuji Hashimoto, Kazuya Osaki, Ryuji Harada, and Koichiro Nomura

Subjects
medicine.medical_specialty, Blood transfusion, biology, business.industry, medicine.medical_treatment, Incidence (epidemiology), T-cell leukemia, Gastroenterology, Surgery, Antigen, Internal medicine, medicine, biology.protein, Hemodialysis, Antibody, business
Abstract

輸血を受ける機会の多い血液透析中の慢性腎不全患者234例について, 血清抗ATLA抗体を測定, HTLV-1感染と輸血との関連について検討し, 以下の結果を得た. 1) 鹿児島県下の血液透析患者の抗ATLA抗体陽性率は33.8%で, 鹿児島県一般健常人の陽性率11.7%より高率であった (p

Published
1986

Catalog

Books, media, physical & digital resources
See catalog results